Found: 15
Select item for more details and to access through your institution.
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 858, doi. 10.3390/cancers16050858
- By:
- Publication type:
- Article
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1983, doi. 10.3390/cancers15071983
- By:
- Publication type:
- Article
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 150, doi. 10.3390/cancers14010150
- By:
- Publication type:
- Article
Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10977-1
- By:
- Publication type:
- Article
Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 5, p. 457, doi. 10.1007/s40272-021-00463-1
- By:
- Publication type:
- Article
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 4, p. e168, doi. 10.1016/j.clml.2023.12.016
- By:
- Publication type:
- Article
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 11, p. 1, doi. 10.1002/pbc.31286
- By:
- Publication type:
- Article
Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31101
- By:
- Publication type:
- Article
Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31123
- By:
- Publication type:
- Article
Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31091
- By:
- Publication type:
- Article
Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐rearranged, therapy‐related acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30964
- By:
- Publication type:
- Article
KIT‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 4, p. 1, doi. 10.1002/pbc.30898
- By:
- Publication type:
- Article
Neither iatrogenic nor hereditary cause: A rare case of anaphylaxis to low sorb tubing used for infusions.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28800
- By:
- Publication type:
- Article
Rare Case of Hybrid Oncocytoma and Chromophobe Renal Cell Carcinoma in a Pediatric Patient.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Non‐myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita.
- Published in:
- Pediatric Transplantation, 2022, v. 26, n. 2, p. 1, doi. 10.1111/petr.14157
- By:
- Publication type:
- Article